Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Total Liabilities: 2011-2024

Historic Total Liabilities for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $70.8 million.

  • Mimedx Group's Total Liabilities rose 27.29% to $80.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.0 million, marking a year-over-year increase of 27.29%. This contributed to the annual value of $70.8 million for FY2024, which is 26.49% down from last year.
  • As of FY2024, Mimedx Group's Total Liabilities stood at $70.8 million, which was down 26.49% from $96.3 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Total Liabilities registered a high of $110.6 million during FY2020, and its lowest value of $70.8 million during FY2024.
  • Moreover, its 3-year median value for Total Liabilities was $96.3 million (2023), whereas its average is $88.0 million.
  • In the last 5 years, Mimedx Group's Total Liabilities increased by 1.65% in 2022 and then dropped by 26.49% in 2024.
  • Over the past 5 years, Mimedx Group's Total Liabilities (Yearly) stood at $110.6 million in 2020, then declined by 13.80% to $95.4 million in 2021, then rose by 1.65% to $96.9 million in 2022, then fell by 0.61% to $96.3 million in 2023, then decreased by 26.49% to $70.8 million in 2024.